Best Life Sciences Platforms and Tools Companies in Finland
The 45 best Life Sciences Platforms and Tools companies in Finland in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: CurifyLabs.
- Precedence Research
- ResearchAndMarkets.com
Our analysis of 50 Life Sciences Platforms and Tools companies
$4.8b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Platforms and Tools companies in Finland
| # | Company | Last round | Disclosed funding | Stage | Employees | Founded | Founder | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Aidian Provider clinical diagnostic and hygiene monitoring tests | — | — | Acquired | 300 | 1974 | Juho Himberg CEO | 12 patents Point‑of‑care blood collection devices and rapid strand‑invasion nucleic‑acid diagnostic assays. | — |
| 2 | Anygraaf Provider of print & publishing services | — | — | Unfunded | 80 | 1998 | Andy Hunn CEO & President | 9 patents Image compression via raster segmentation techniques | — |
| 3 | Biohit Healthcare Diagnostics products and servcies | — | — | Public | 42 | 1988 | — | — | — |
| 4 | Biomedicum Genomics Provider of genomic services to life science research purpose | — | — | Unfunded | — | 2007 | Outi Monni Co-Founder | — | — |
| 5 | BioSiteHisto CRO focused on tissue- and cell-based technologies | — | — | Deadpooled | — | 2012 | Yvonne Zar Berglund CEO | — | — |
| 6 | BN Products and Services Products and Services for Genomics, Proteomics, Drug Discovery, Clinical Chemistry and Cell Biology | — | — | Deadpooled | — | 2008 | Stuart Webb Co-Founder | 98 patents Electric power distribution hardware and fire suppression devices for industrial safety. | — |
| 7 | Bonalive Biomaterials Developer of biomaterials for bone regeneration | — | — | Unfunded | 47 | 2010 | — | 45 patents Bioactive bone implant materials and paste for orthopedic infection treatment. | 2 job openings |
| 8 | CM Technologies Developer of cell imaging products. The company's product Cell-IQ enables real-time monitoring of… | — | — | Acquired | 50 | 2002 | — | — | — |
Top 12 Life Sciences Platforms and Tools companies in Finland
#1
Series A · Helsinki, Uusimaa · founded 2021 · 16 employees$11.5Mraised▾
Provider of digital 3D printing solutions for personalized medicine. The company has developed a platform that enables sustainable, quality-controlled production of personalized medicine through its pharmaceutical printing technology. It is a smart drug formulation platform that incorporates cutting-edge technology to redefine the drug compounding process.
- May 2025Conventional Debt$1.1M
- May 2025Series A$7.6M
- Apr 2023Grant (prize money)$2.7M
- Jan 2023Grant (prize money)—
#2
Funding Raised · Kuopio, North Savo · founded 2017 · 8 employees$1.7Mraised▾
Afekta Technologies is a spin-off company based on metabolic profiling at the University of Eastern Finland. The company offers mass spectrometry-based comprehensive metabolomics services including food science, nutrition, colonic microbiota, in-vitro studies, and others. The company also offers consulting services.
- Feb 2023Grant (prize money)$312.4K
- Sep 2021Grant (prize money)$1.1M
- Sep 2018Grant (prize money)$326.3K
#3
Series A · Helsinki, Uusimaa · founded 2019 · 11 employees$10.6Mraised▾
Rappta Therapeutics discovers and develop anticancer drugs using small molecule. The company's proprietary technology uses small molecule to activate protein phosphatase 2A (PP2A), that is a tumour suppressor protein. The company's drug molecules bind to the subunits of PP2A complex to target oncogenic cells.
- Oct 2020Series A$10.6M
- Seed—
#4
Seed · Tampere, Pirkanmaa · founded 2015 · 18 employees$2.6Mraised▾
Provider of cloud-based biosensors for diagnostic applications. It has developed a lab-on-chip platform for the detection of multiple analytes that uses a proprietary mass sensitive micro-array (MSMA) that is based on film-bulk acoustic resonance (FBAR) technology combined with application-specific integrated circuits. The platform is compatible with several sample types, including saliva, blood, and food, and is capable of detecting both proteins and nucleic acids.
- Mar 2022Grant (prize money)$55.7K
- Mar 2019Grant (prize money)$2.8M
- Nov 2016Seed$2.6M
#5
Seed · Oulu, North Ostrobothnia · founded 2018$1.9Mraised▾
Developer of microfluidics and microtechnology solutions for drug development. The company is developing high throughput biological barriers on chips to mimic human biologies such as vascular, lung, and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability, and toxicity testing with in-vivo like dynamic cell cultures.
- Apr 2022Seed$1.3M
- Apr 2022Grant (prize money)$317.5K
- Apr 2020Seed$596.1K
- Dec 2018Seed—
#6
Acquired · Tampere, Pirkanmaa · founded 2015 · 59 employees$2.4Mraised▾
Grundium provides a portable scanning microscope for medical researchers. It offers its flagship product Grundium Ocus for digital pathology and helps in telepathology also. The microscope is having an automated X and Y stage, Z-focus, high resolution, and others.
- Jun 2020Grant (prize money)$56.2K
- Jul 2018Grant (prize money)$2.3M
- Dec 2017Series A$2.4M
#7
Series A · Turku, Varsinais-suomi · founded 2001$6.2Mraised▾
Vivoxid develops, manufactures, and markets biomaterial products for the medical device sector. Its products include FiberLive® that is used in the manufacturing of load bearing and resorbable device solutions for the trauma, spine, CMF and sports medicine markets and MetAlive® which provides safe and firm attachment to soft tissue; drastically reducing inflammatory reactions that speed up the healing response without scar tissue side effects. It sold its technologies FiberLive® to Purac and MetAlive® to ID Creations in August 2012.
- Sep 2005Series A$6.2M
#8
Deadpooled · Helsinki, Uusimaa · founded 2007$4.2Mraised▾
Plex Press is a spin-off from Finnish technology research center. It has developed a gene expression analysis platform called TRAC technology, originally developed for gene expression analysis in bioprocess applications. The company claims to have engaged in more than 50 projects using this TRAC technology in the field of Pharma and research.
- Apr 2012Seed$1.4M
- May 2009Seed$2.8M
#9
Acquired · Oulunsalo, Northern Ostrobothnia · founded 2010 · 90 employees$2.4Mraised▾
Ginolis is the developer of liquid handling robots for use in laboratories involved in research in the field of life sciences or healthcare. The product offerings can perform various lab activities such as micro assembly, lateral flow device assembly, quality control and design for automation. The Delilah robotic platform is a multi-functional automation platform for diagnostic test manufacturing and laboratory processes. It can be used both as a stand alone unit or a fully robotic automation solution.
- Jan 2019Grant (prize money)$571.6K
- Feb 2017Series A—
- Sep 2016Seed$2.4M
- May 2015Grant (prize money)$451.5K
#10
Acquired · Helsinki, Uusimaa · founded 2007$4.2Mraised▾
High throughput gene expression analysis
#11
Acquired · Oulu, North Ostrobothnia · founded 2008$1.8Mraised▾
Sensapex has developed their own proprietary technology based on electrophysiology and wide field fluorescence imaging. The products include UM-scope and UMP micromanipulation system. UM-scope has its application in dual patch clamp and wide field fluorescence imaging, in vivo optogenetics, and 4-channel in vitro patch clamp experiments whereas UMP micromanipulation system has micromanipulator and a touchscreen controller, and rotary wheel remote interface.
- Jan 2015Series A$1.8M
#12
Seed · Helsinki, Uusimaa · founded 2009 · 12 employees$1Mraised▾
MediSapiens is a bioinformatics company, based in Helsinki, Finland and Cambridge, Massachusetts, with a background in pharmaceutical research and translational genomics. The company provides pharmaceutical and biomedical research organizations with tools that help them design more effective personalized drugs against life-threatening diseases. MediSapiens creates powerful and intuitive software platforms to manage, integrate, and visualize complex multi-dimensional datasets, such as genomic sequencing data. The company's goal is to drive medicine forward by developing tools that provide scientists with a way to quickly analyze and visualize vast amounts of data and turn it into knowledge that fuels innovation.
- Jun 2010Seed$1M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Platforms and Tools coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Bioinformatics is moving in Finland
A read on the academic research around Bioinformatics — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 276 Finland-affiliated papers.
- University of Helsinki77
- Institute for Molecular Medicine Finland31
- University of Turku29
- Helsinki University Hospital26
- Tampere University22
- Genome1→14
- Drug1→6
- Annotation1→4
- Transcriptome1→4
- Gene1→8
- Microbiome5
- Gene4
- Computational biology3
- Gut microbiome3
- Gut flora3
Where bioinformatics is researched across Finland
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.